Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease

Non ancora tradotto Non ancora tradotto
Categoria Primary study
Registry of Trialsclinicaltrials.gov
Year 2010

This article is not included in any systematic review

This article is part of the following publication threads:
Loading references information
This study in patients with moderately to severely active Crohn\'s disease is designed to establish the efficacy and safety of vedolizumab for the induction of clinical response and remission.
Epistemonikos ID: 0af9b93c5cf0f2d206d142017e847977f40efc8f
First added on: Jul 30, 2018